Clinical Journal of the American Society of Nephrology (CJASN)

By American Society of Nephrology

What's Clinical Journal of the American Society of Nephrology (CJASN) about?

Clinical Journal of the American Society of Nephrology (CJASN) publishes high quality research relevant to clinical nephrology. Now one of the most widely-read and referenced kidney journals, physicians read CJASN to learn about the most important advances in clinical and translational research in nephrology.

Download our free app to listen on your phone

Clinical Journal of the American Society of Nephrology (CJASN) episodes:

12.14.2023
Kidney Measures and Venous Thromboembolism
Dr. Zhong Zheng provides an overview of his study, "Association of Estimated Glomerular Filtration Rate and Albuminuria with Venous Thromboembolism," on behalf of his colleagues.
11.20.2023
Participant Experience in the KPMP - Spanish Language
Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in Spanish.
11.20.2023
Participant Experience in the KPMP
Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in English.
11.20.2023
Resveratrol in CKD
Dr. Diana I. Jalal and Colin Gimblet discuss the findings of their study, "Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial," on behalf of their colleagues.
11.17.2023
Tubular Biomarkers and Kidney Histopathology in Diabetes
Dr. Christine Limonte summarizes the main findings from her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes," on behalf of her colleagues.
11.17.2023
Metabolomics and Neurocognition
Dr. Arthur M. Lee provides an overview of the results of his study, "Circulating Metabolomic Associations with Neurocognitive Outcomes in Pediatric CKD," on behalf of his colleagues.
11.10.2023
Interstitial Eosinophilic Aggregates Predict Kidney Failure
Dr. Hattori Koki discusses the results of his study, "Interstitial Eosinophilic Aggregates and Kidney Outcome in Patients with CKD," on behalf of his colleagues.
11.10.2023
Nurse Practitioner Care in CKD
Dr. Matthew James, Ellen Novak, and Tayler Scory summarize the results of their study, "Nurse Practitioner Care Compared to Primary Care or Nephrologist Care in Early CKD," on behalf of their colleagues.
11.08.2023
Cardiovascular Prevention in CKD
Dr. Reza Malekzadeh gives an overview of the results of his article "Fixed-Dose Combination Therapy for Prevention of Cardiovascular Diseases in CKD: An Individual Participant Data Meta-Analysis," on behalf of his colleagues.
11.08.2023
C3G Ig-MPGN and Complement Rare Variants
Drs. Marie-Sophie Meuleman and Sophie Chauvet provide a summary of their study, "Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative Glomerulonephritis," on behalf of their colleagues.
11.02.2023
An Interview with Tristan de Nattes, the Second-Place Winner of the 2023 CJASN Trainee of the Year Competition
CJASN Editor-in-Chief Rajnish Mehrotra interviews Tristan de Nattes, the 2023 CJASN Trainee of the Year second-place winner, on his article, "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies."
11.02.2023
An Interview with Rosa D. Wouda, the First-Place Winner of the 2023 CJASN Trainee of the Year Competition
CJASN Editor-in-Chief Rajnish Mehrotra interviews 2023 CJASN Trainee of the Year winner Rosa D. Wouda on her article, "Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements."
10.09.2023
HPA Axis Suppression in Nephrotic Syndrome
Dr. Rajiv Sinha discusses the findings from his study, "HPA Axis in Single- versus Divided-Dose Prednisolone for First Episode Nephrotic Syndrome: An Open Label RCT," on behalf of his colleagues.
10.09.2023
PLA2R Antibodies and Treatment Response
Drs. Daniel Cattran and Sean Barbour summarize the main results of their study, "Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy," on behalf of their colleagues.
09.08.2023
Dasatinib Nephrotoxicity and Pharmacokinetics
Drs. Benjamin Adegbite and Evren Azeloglu discuss the results of their study, "Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity," on behalf of their colleagues.
09.08.2023
eGFRcys and eGFRcr Discrepancy
Dr. Morgan Grams provides an overview of the findings of her study, "Discrepancies between Cystatin C–Based and Creatinine-Based Estimated Glomerular Filtration Rates," on behalf of her colleagues.
08.08.2023
Timing KRT in Children and Young Adults
Dr. Nick Larkins discusses the findings of his study, "Timing of Kidney Replacement Therapy among Children and Young Adults," on behalf of his colleagues.
08.08.2023
COVID-19–Associated AKI
Dr. Farrukh M. Koraishy summarizes the results of his study, "Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative," on behalf of his colleagues.
07.10.2023
Nirmatrelvir/Ritonavir in Kidney Transplant Patients
Mr. Pierre Giguère and Dr. Swapnil Hiremath provide an overview of their study, "Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients," on behalf of their colleagues.
07.10.2023
ICI-Induced Kidney Adverse Events
Dr. Gangadharan Komala provides a summary of the results of his study, "Kidney Adverse Events Associated with Immune Checkpoint Inhibitor Therapy," on behalf of his colleagues.
06.08.2023
Kidney Stone Events after Kidney Transplant
Drs. Calyani Ganesan, Alan Pao, and John Leppert discuss the results of their study, "Kidney Stone Events after Kidney Transplant in the United States," on behalf of their colleagues.
06.08.2023
Albuminuria and Outcomes with Canagliflozin
Dr. Hiddo J.L. Heerspink summarizes the findings of his study, "Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR," on behalf of his colleagues.
05.08.2023
CKD Complex Interventions: Realist Review
Dr. Dominic Taylor provides a summary of his study "Complex Interventions across Primary and Secondary Care to Optimize Population Kidney Health," on behalf of his colleagues.
05.08.2023
COVID-19 or Vaccinated Patients' Kidney Biopsies
Drs. Maria de las Mercedes Noriega and Faeq Husain-Syed discuss the results of their study "Kidney Biopsy Findings in Patients with SARS-CoV-2 Infection or After COVID-19 Vaccination," on behalf of their colleagues.
04.10.2023
Molecular Diagnosis of Kidney Transplant Rejection
Dr. Tristan de Nattes discusses the results of his study "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies," on behalf of his colleagues.
04.10.2023
COVID-19 in Advanced CKD
Mr. Jian Roushani and Dr. Peter G. Blake provide an overview of their study "Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics," on behalf of their colleagues.
03.08.2023
The ASCENT Intervention: A Randomized, Effectiveness-Implementation Trial
Drs. Rachel Patzer and Stephen Pastan discuss the results of their study "The ASCENT Intervention to Improve Access and Reduce Racial Inequalities in Kidney Waitlisting," on behalf of their colleagues.
03.08.2023
Metabolomics of Ultra-Processed Food and CKD
Dr. Casey Rebholz provides a summary of the findings from the study "Metabolomic Markers of Ultra-Processed Food and Incident CKD," on behalf of her colleagues.
02.08.2023
Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population
Dr. Nora Franceschini and Ms. Kaylia Reynolds summarize the findings of their study "Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population," on behalf of their colleagues.
02.08.2023
Risk Factors for Pruritus in CKD
Dr. Kendra Wulczyn discusses the results of her study "Incidence and Risk Factors for Pruritus in Patients with Nondialysis CKD," on behalf of her colleagues.
01.10.2023
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases
Dr. Killian Donovan provides an overview of the conclusions from his study "Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases," on behalf of his colleagues.
01.10.2023
A Health Survey-Based Prediction Equation for Incident CKD
Dr. Manish Sood summarizes the findings from his study, "A Health Survey-Based Prediction Equation for Incident CKD," on behalf of his colleagues.
01.10.2023
Relapse in MPO-AAV with Kidney Involvement
Drs. Fernando Fervenza, Marta Casal Moura, and Ulrich Specks discuss the results of their study, "Maintenance of Remission and Risk of Relapse in Myeloperoxidase Positive Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Renal Involvement."
11.04.2022
An Interview with Bart J. Kramers, the First-Place Winner of the 2022 CJASN Trainee of the Year Competition
CJASN Editor-in-Chief Rajnish Mehrotra interviews 2022 CJASN Trainee of the Year winner Bart J. Kramers on his article, "Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD."
11.04.2022
An Interview with Insa Schmidt, the Second-Place Winner of the 2022 CJASN Trainee of the Year Competition
CJASN Editor-in-Chief Rajnish Mehrotra interviews Insa Schmidt, the 2022 CJASN Trainee of the Year second-place winner, on her article, "Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease."
11.04.2022
Prediction of Kidney Failure in Type 2 Diabetes
Helena Bleken Østergaard discusses the results from her study "Development and Validation of a Lifetime-Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes," on behalf of her colleagues.
10.27.2022
dd-cfDNA in Pediatric Kidney Transplantation
Dr. Raja Dandamudi summarizes the results of his study "Longitudinal Evaluation of Donor-Derived Cellfree DNA in Pediatric Kidney Transplantation," on behalf of his colleagues.
10.25.2022
Toxic Occupational Exposures and Membranous Nephropathy
Dr. Marion Cremoni discusses the findings from her study "Toxic Occupational Exposures and Membranous Nephropathy," on behalf of her colleagues.
09.26.2022
Work Functioning among Kidney Transplant Recipients
Dr. Tim Knobbe summarizes the results of his study "Employment Status and Work Functioning among Kidney Transplant Recipients," on behalf of his colleagues.
09.21.2022
POCUS Training in Nephrology Fellowship
Drs. Catherine Moore, Charles O'Neill, and Daniel Ross discuss the findings from their study, "Point-of-Care Ultrasound Training during Nephrology Fellowship," on behalf of their colleagues.
08.10.2022
Urine Uromodulin and Kidney Fibrosis
Drs. Dennis Moledina, Hannah Melchinger, and Frida Calderon provide a summary of their article "Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis," on behalf of their colleagues.
07.28.2022
MR Study of FGF23 and Heart Failure
Dr. Cassianne Robinson-Cohen and Dr. Elvis Akwo discuss findings from their study, "Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart Failure" on behalf of their colleagues.
07.26.2022
Deep Learning of IgAN Biopsy
Dr. Riccardo Magistroni and Dr. Johanna Chester provide a summary of their study "Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images," on behalf of their colleagues.
07.19.2022
Two-Year Kidney Outcomes in Premature Infants
Dr. Sangeeta Hingorani discusses findings from her study, "Prevalence and Risk Factors for Kidney Disease and Elevated Blood Pressure in 2-Year-Old Children Born Extremely Premature," on behalf of her colleagues.
06.10.2022
An Integer-Based Score to Predict Tertiary Hyperparathyroidism
Dr. Yumie Rhee and Dr. Namki Hong summarize the results of their study, "Machine Learning–Derived Integer-Based Score and Prediction of Tertiary Hyperparathyroidism among Kidney Transplant Recipients," on behalf of their colleagues.
06.06.2022
Deep Learning for LVEF in Dialysis
Drs. Akhil Vaid and Lili Chan describe the findings of their study, "Automated Determination of Left Ventricular Function using Electrocardiogram Data in Patients on Maintenance Hemodialysis," on behalf of their colleagues.
05.31.2022
Global Variation in PD Time on Therapy
Drs. Mark Lambie, Jeff Perl, and Jenny Shen summarize the results of their study "Variation in Peritoneal Dialysis Time on Therapy by Country," on behalf of their colleagues.
05.16.2022
APOL1 High-Risk Genotypes and Albuminuria in Africa
Dr. Jean-Tristan Brandenburg discusses the findings from his study "Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations," on behalf of his colleagues.
04.26.2022
GWAS Reveals Hematuria Mechanisms
Dr. Moumita Barua and Dr. Sarah Gagliano Taliun summarize the results of their study "GWAS of Hematuria," on behalf of their colleagues.
04.11.2022
Provider Perspectives and Clinical Outcomes with Inpatient Telenephrology
Dr. Lagu Androga discusses findings from his study "Provider Perspectives and Clinical Outcomes with Inpatient Telenephrology," on behalf of his colleagues.

What's Clinical Journal of the American Society of Nephrology (CJASN) about?

Download our free app to listen on your phone

Clinical Journal of the American Society of Nephrology (CJASN) episodes:

Kidney Measures and Venous Thromboembolism

Participant Experience in the KPMP - Spanish Language

Participant Experience in the KPMP

Resveratrol in CKD

Tubular Biomarkers and Kidney Histopathology in Diabetes

Metabolomics and Neurocognition

Interstitial Eosinophilic Aggregates Predict Kidney Failure

Nurse Practitioner Care in CKD

Cardiovascular Prevention in CKD

C3G Ig-MPGN and Complement Rare Variants

An Interview with Tristan de Nattes, the Second-Place Winner of the 2023 CJASN Trainee of the Year Competition

An Interview with Rosa D. Wouda, the First-Place Winner of the 2023 CJASN Trainee of the Year Competition

HPA Axis Suppression in Nephrotic Syndrome

PLA2R Antibodies and Treatment Response

Dasatinib Nephrotoxicity and Pharmacokinetics

eGFRcys and eGFRcr Discrepancy

Timing KRT in Children and Young Adults

COVID-19–Associated AKI

Nirmatrelvir/Ritonavir in Kidney Transplant Patients

ICI-Induced Kidney Adverse Events

Kidney Stone Events after Kidney Transplant

Albuminuria and Outcomes with Canagliflozin

CKD Complex Interventions: Realist Review

COVID-19 or Vaccinated Patients' Kidney Biopsies

Molecular Diagnosis of Kidney Transplant Rejection

COVID-19 in Advanced CKD

The ASCENT Intervention: A Randomized, Effectiveness-Implementation Trial

Metabolomics of Ultra-Processed Food and CKD

Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population

Risk Factors for Pruritus in CKD

Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases

A Health Survey-Based Prediction Equation for Incident CKD

Relapse in MPO-AAV with Kidney Involvement

An Interview with Bart J. Kramers, the First-Place Winner of the 2022 CJASN Trainee of the Year Competition

An Interview with Insa Schmidt, the Second-Place Winner of the 2022 CJASN Trainee of the Year Competition

Prediction of Kidney Failure in Type 2 Diabetes

dd-cfDNA in Pediatric Kidney Transplantation

Toxic Occupational Exposures and Membranous Nephropathy

Work Functioning among Kidney Transplant Recipients

POCUS Training in Nephrology Fellowship

Urine Uromodulin and Kidney Fibrosis

MR Study of FGF23 and Heart Failure

Deep Learning of IgAN Biopsy

Two-Year Kidney Outcomes in Premature Infants

An Integer-Based Score to Predict Tertiary Hyperparathyroidism

Deep Learning for LVEF in Dialysis

Global Variation in PD Time on Therapy

APOL1 High-Risk Genotypes and Albuminuria in Africa

GWAS Reveals Hematuria Mechanisms

Provider Perspectives and Clinical Outcomes with Inpatient Telenephrology